🇩🇪 Germany · EU Public Tender
Arzneimittelrabattvereinbarung nach § 130 a Abs. 8 SGB V zu den Wirkstoffen Blutgerinnungsfaktor IX, VIII sowie von Willebrand-Faktor und Blutgerinnungsfaktor VIII in Kombination
🏛️ AOK Baden-Württemberg · 📍 Stuttgart
214 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Octapharma GmbH |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.